Helixmith ranked among the top searched stocks on 6 days within the past month.
As of 10:30 AM on the 20th, Helixmith is trading at 19,100 KRW, down 11.37% from the previous day. This represents a 65.34% decline compared to September 16. Helixmith is known as a specialized company developing new drugs focused on gene therapy.
Today, foreigners have a net purchase of 15,000 shares of Helixmith, and institutions have a net purchase of 6,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 172,719 shares, while foreigners and institutions have net sold 34,235 shares and 111,442 shares, respectively.
On October 19, Helixmith was a market issue with the headline "Plummeting near the lower limit... Concerns over inclusion in the management stock list."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

